Success Stories: Swift NIW Success: Chemist Achieves Approval Without an RFE

 

Client’s Testimonial:

“Thank you so much for informing me about the approval! I honestly thought it could take more than a year to get a decision or was very likely to be an RFE, so I didn't check the case for a while and was truly surprised today. Thank you for your exceptionally professional work to get my weak case approved without an RFE.”


On August 18th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Team Lead in the Field of Chemistry (Approval Notice).


General Field: Chemistry

Position at the Time of Case Filing: Team Lead

Country of Origin: China

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: August 18th, 2025

Processing Time: 5 months and 12 days


Case Summary:      

A PhD holder in chemistry from China, specializing in pharmaceutical safety, approached North America Immigration Law Group (NAILG) for assistance with an EB-2 NIW (National Interest Waiver) petition. After reviewing the client's qualifications, which included peer-reviewed publications, a growing citation record, and meaningful peer review service, we were confident in the client's eligibility for the NIW category. The petition was filed on March 6, 2025, and was approved on August 18, 2025 - a total processing time of 5 months and 12 days. This timely approval reflects both the client's strong background and the strength of the case we presented.

Proposed Endeavor: Enhancing Pharmaceutical Safety through Advanced Analytical Chemistry

The client's proposed endeavor focuses on developing advanced analytical methods to identify pharmaceutical ingredient impurities in pharmaceutical packaging and medical devices. By ensuring that harmful contaminants are detected early, this work addresses a critical public health need: improving the safety and effectiveness of drugs and medical products. This research directly aligns with US national interests in drug safety, public health, and manufacturing standards.

Notable Achievements Supporting the Petition  To demonstrate the client's significance and impact in the field, we highlighted:

  • Publications: 4 peer-reviewed journal articles (2 first-authored), 9 abstracts (7 first-authored), and 4 technical reports, including work published in a highly ranked analytical chemistry journal.
  • Citations: The client's work has received 65 citations, with one paper ranking in the top 20% most cited in chemistry for its publication year.
  • Peer review service: Invited to review for an authoritative international journal, a recognition reserved for trusted experts.
  • Research recognition: Contributions supported by the National Science Foundation (NSF), reflecting their value to US national interests.
  • Practical impact: Research that equips pharmaceutical companies with tools to detect harmful compounds early, reducing the likelihood of recalls and safeguarding public health.
Recognition from Experts in the Field

The petition was further supported by two strong recommendation letters from established experts. These testimonials emphasized that the client's work in advanced analytical chemistry provides vital tools for safeguarding pharmaceutical safety and addressing broader challenges in environmental sustainability. As one expert explained:

"Overall, the outcomes of [Client’s] studies underscore his position as a significant contributor to environmental sustainability and the advancement of analytical techniques in the scientific community.”

Such recognition provides independent confirmation of the originality and impact of the client's work, reinforcing why continued contributions in this area are of clear benefit to the United States.

NIW Approval and Outlook

The case was approved in 5 months and 12 days without receiving any RFE. This successful outcome reflects both the client's strong qualifications and NAILG's meticulous petition strategy. We are proud to have supported this chemist in securing NIW approval and look forward to the client's continued contributions to improving drug safety and advancing public health in the United States.